Johann de Bono The Institute of Cancer Research, Drug Development Unit United Kingdom

Professor Johann de Bono is Regius Professor of Cancer Research and a Professor in Experimental Cancer Medicine at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust. He is also the Director of the Drug Development Unit, overseeing the conduct of phase I trials, with a particular interest in innovative trial designs, circulating biomarkers and prostate cancer. Additionally, he leads the Prostate Cancer Targeted Therapy Group and the Cancer Biomarkers group.

Wednesday 10 June 2026

Time	Session

15:20 16:55	Symposium: Advances in Clinical Trial Design (liquid biopsies) Title to be announced AlbertoBardelli Speaker Italy Proffered Paper: Selected from Abstracts - to be announced in 2026 Integrative analyses of circulating biomarker studies in advanced prostate cancer Johannde Bono Speaker United Kingdom Proffered Paper: Selected from Abstracts - to be announced in 2026 Reading the Molecular Future of Colon Cancer in the Blood Silvia Marsoni Speaker Italy Room P1+2+3

Time

Session

15:20

16:55

Symposium: Advances in Clinical Trial Design (liquid biopsies)

Title to be announced

AlbertoBardelli Speaker Italy
Proffered Paper: Selected from Abstracts - to be announced in 2026
Integrative analyses of circulating biomarker studies in advanced prostate cancer

Johannde Bono Speaker United Kingdom
Proffered Paper: Selected from Abstracts - to be announced in 2026
Reading the Molecular Future of Colon Cancer in the Blood

Silvia Marsoni Speaker Italy

Room P1+2+3